These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34531126)

  • 21. Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Sasso EM; Muraki K; Eaton-Fitch N; Smith P; Lesslar OL; Deed G; Marshall-Gradisnik S
    Mol Med; 2022 Aug; 28(1):98. PubMed ID: 35986236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome: Similarities and differences of two peas in a pod.
    Qanneta R
    Reumatol Clin (Engl Ed); 2022 Dec; 18(10):626-628. PubMed ID: 36435560
    [No Abstract]   [Full Text] [Related]  

  • 23. Historical Insight into Infections and Disorders Associated with Neurological and Psychiatric Sequelae Similar to Long COVID.
    Stefano GB
    Med Sci Monit; 2021 Feb; 27():e931447. PubMed ID: 33633106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is SARS-CoV-2 the only cause of long-COVID?
    Pintos-Pascual I; Moreno-Torres V; Ibánez-Estéllez F; Corrales-Rodriguez P; Treviño A; Corpas M; Corral O; Soriano V; de Mendoza C
    AIDS Rev; 2022 Dec; 24(4):183-196. PubMed ID: 36427058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long COVID-19 and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Correspondence.
    Mungmunpuntipantip R; Wiwanitkit V
    Reumatol Clin (Engl Ed); 2023 Feb; 19(2):119. PubMed ID: 36739119
    [No Abstract]   [Full Text] [Related]  

  • 26. The Importance of Listening in Treating Invisible Illness and Long-Haul COVID-19.
    Wall D
    AMA J Ethics; 2021 Jul; 23(7):E590-595. PubMed ID: 34351274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term sequelae of COVID-19 (myalgic encephalomyelitis): An international cross-sectional study.
    Shaheen N; Shaheen A
    Medicine (Baltimore); 2022 Nov; 101(45):e31819. PubMed ID: 36397426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Approaching recovery from myalgic encephalomyelitis and chronic fatigue syndrome: Challenges to consider in research and practice.
    Devendorf AR; Jackson CT; Sunnquist M; Jason LA
    J Health Psychol; 2019 Sep; 24(10):1412-1424. PubMed ID: 29182007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are Myalgic Encephalomyelitis and chronic fatigue syndrome different illnesses? A preliminary analysis.
    Jason LA; Sunnquist M; Brown A; Evans M; Newton JL
    J Health Psychol; 2016 Jan; 21(1):3-15. PubMed ID: 24510231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Definitions and aetiology of myalgic encephalomyelitis: how the Canadian consensus clinical definition of myalgic encephalomyelitis works.
    Carruthers BM
    J Clin Pathol; 2007 Feb; 60(2):117-9. PubMed ID: 16935963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post COVID syndrome: a new challenge for medicine.
    Tirelli U; Taibi R; Chirumbolo S
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4422-4425. PubMed ID: 34227079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humility and Acceptance: Working Within Our Limits With Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Décary S; Gaboury I; Poirier S; Garcia C; Simpson S; Bull M; Brown D; Daigle F
    J Orthop Sports Phys Ther; 2021 May; 51(5):197-200. PubMed ID: 33930983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from?
    Toogood PL; Clauw DJ; Phadke S; Hoffman D
    Pharmacol Res; 2021 Mar; 165():105465. PubMed ID: 33529750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors?
    Mantovani E; Mariotto S; Gabbiani D; Dorelli G; Bozzetti S; Federico A; Zanzoni S; Girelli D; Crisafulli E; Ferrari S; Tamburin S
    J Neurovirol; 2021 Aug; 27(4):631-637. PubMed ID: 34341960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
    Moghimi N; Di Napoli M; Biller J; Siegler JE; Shekhar R; McCullough LD; Harkins MS; Hong E; Alaouieh DA; Mansueto G; Divani AA
    Curr Neurol Neurosci Rep; 2021 Jun; 21(9):44. PubMed ID: 34181102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Post-COVID syndrome with fatigue and exercise intolerance: myalgic encephalomyelitis/chronic fatigue syndrome].
    Renz-Polster H; Scheibenbogen C
    Inn Med (Heidelb); 2022 Aug; 63(8):830-839. PubMed ID: 35925074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS).
    Haffke M; Freitag H; Rudolf G; Seifert M; Doehner W; Scherbakov N; Hanitsch L; Wittke K; Bauer S; Konietschke F; Paul F; Bellmann-Strobl J; Kedor C; Scheibenbogen C; Sotzny F
    J Transl Med; 2022 Mar; 20(1):138. PubMed ID: 35317812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post COVID fatigue: Can we really ignore it?
    Sharma P; Bharti S; Garg I
    Indian J Tuberc; 2022 Apr; 69(2):238-241. PubMed ID: 35379408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-viral fatigue in COVID-19: A review of symptom assessment methods, mental, cognitive, and physical impairment.
    Campos MC; Nery T; Starke AC; de Bem Alves AC; Speck AE; S Aguiar A
    Neurosci Biobehav Rev; 2022 Nov; 142():104902. PubMed ID: 36202253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.